Am Soc NephrologyOvjeren akaunt

@ASNKidney

ASN: A World Without Kidney Diseases. Other ASN handles: , , , , , . Also on Instagram.

Washington, DC
asn-online.org
Prikaz prijenosa uživo Prijenos UŽIVO
Vrijeme pridruživanja: listopad 2010.
1.381 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @ASNKidney

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ASNKidney

  1. prije 2 sata

    The regular Global Perspectives feature in examines how diseases are managed in countries around the world. The latest piece examines management and funding in Brazil:

    1 korisnik označava da mu se sviđa
    Poništi
  2. prije 2 sata

    Bundled Payment Reform and Facility Closures in New in JASN:

    Poništi
  3. proslijedio/la je Tweet
    2. velj

    Check out the podcast by and I on our recent article published at “Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy”

    ., ASN’s newest journal, has just posted its first podcast. and Konstantinos Leventakos discuss their article, “Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy.” Listen here:
    11 proslijeđenih tweetova 30 korisnika označava da im se sviđa
    Poništi
  4. prije 21 sat

    Consenting for or Its Alternative: Systematic Process Is Needed "It is imperative that the nephrology community improves informed consent in accordance with legal and ethical benchmarks..." From a new Perspective in :

    3 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  5. 4. velj

    Are bisphosphonates safe for adults with CKD? “This study shows that oral bisphosphonates are safe for people with moderate to severe , at least in relation to mortality outcomes....”

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  6. 4. velj

    A systematic review and meta-analysis in found peritoneal and hemodialysis “carry equivalent survival benefits.” “Reported differences in survival...largely reflect a combination of factors that are unrelated to clinical efficacy.”

    6 proslijeđenih tweetova 5 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    3. velj

    “Our findings suggest that oATP mitigates allograft rejection by inhibiting T cell, B cell, and macrophage activity and indicate a potential role for the purinergic system and oATP in solid organ .” New in

    3 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  8. 3. velj

    “For patients undergoing living transplants, persistent mixed chimerism can be achieved to allow complete or partial withdrawal of immunosuppressive drugs.....”

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  9. 3. velj

    Hypothesis as to How a Common Missense Mutation in COL4A3 May Confer Protection against Diabetic Kidney Disease

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    The new Genomics of Kidney Disease article series from will explore the clinical application of to health. The articles in this series will be collected here:

    5 proslijeđenih tweetova 8 korisnika označava da im se sviđa
    Poništi
  11. 3. velj

    “For access, the likelihood of arteriovenous fistula placement and subsequent maturation varied based on specific surgeon characteristics, according to this study.”

    2 korisnika označavaju da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    1. velj

    Diabetic Nephropathy where we were where we are where science may take us a CTC session lead by Dr. Vlado Perkovic & Dr. Katalin Susztak and moderated by Dr. Sylvia Rosas in our Joint Venture with

    Korisnici , , i
    31 proslijeđeni tweet 67 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  13. 3. velj

    “Our findings suggest that oATP mitigates allograft rejection by inhibiting T cell, B cell, and macrophage activity and indicate a potential role for the purinergic system and oATP in solid organ .” New in

    3 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    1. velj

    Congratulations to Dr. Allon and the entire Kidney 360 team! A big moment for the kidney community!

    Announcing the inaugural issue of Kidney360
    7 proslijeđenih tweetova 38 korisnika označava da im se sviđa
    Poništi
  15. 2. velj

    ., ASN’s newest journal, has just posted its first podcast. and Konstantinos Leventakos discuss their article, “Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy.” Listen here:

    7 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    27. sij

    Learn about our newest article type, Innovative Technology and Methodology,

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  17. 31. sij

    From A Case of Primary Hyperoxaluria Type 1 & Combined Liver-Kidney Transplant

    4 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  18. 31. sij

    The new Genomics of Kidney Disease article series from will explore the clinical application of to health. The articles in this series will be collected here:

    5 proslijeđenih tweetova 8 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    31. sij

    In this first of its kind analysis from India, predominantly socioeconomic factors were associated with quality of life scores in patients with Editorial: Patient Perspective:

    13 proslijeđenih tweetova 30 korisnika označava da im se sviđa
    Poništi
  20. 31. sij

    Submissions for Phase II are due TODAY at 5 pm ET.

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi

@ASNKidney još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·